Vezicle™ Liposomal Delivery

Vezicle™ includes phospholipid-based ingredients for professional formulation work involving wetting, dispersion and content uniformity. These are formulation objectives; suitability must be assessed for the individual ingredient and application. We make no absorption or bioavailability claim.

The terminology problem, stated plainly

Phospholipid content alone does not establish a liposomal vesicle structure. When evaluating an ingredient for a finished product, request evidence that supports the terminology and intended claims.

Assessment of a liposomal system requires evidence of phospholipid vesicles and of the relationship between the active and the vesicle structure. Phospholipid content alone does not establish either property.

Request the current product-specific characterisation report when evaluating an ingredient. Evidence for Vitamin K2, Vitamin D3, curcumin, glutathione, vitamin C or coenzyme Q10 must not be assumed to apply to Ferric Pyrophosphate.

How to assess the evidence

The methods below describe an assessment framework, not a statement that every test has been completed for every ingredient. Refer to the product-specific report for the method, conditions and results.

For a dry powder, assess the reconstituted ingredient under a defined protocol. Evidence from a wet manufacturing stage alone does not establish the structure or performance after drying and storage.

Quality control parameters

Current maturity

Qualification status, availability and documentation are assessed per ingredient and batch. Request the current specification, relevant characterisation report and documentation for the intended application. For Ferric Pyrophosphate, confirm the specification and supporting characterisation before relying on structural or performance claims.

Explore the Liposomal Ingredients collection · Read our full terminology standard · See the formulation problem this solves